Search
Now showing items 31-40 of 8848
Clinicopathological significance of ERCC1 expression in breast cancer
(2013-06-01)
The excision repair cross-complementation 1 (ERCC1) enzyme plays an essential role in the nucleotide excision repair pathway and is associated with resistance to platinum-based chemotherapy in different types of cancer. ...
Clinicopathological significance of ERCC1 expression in breast cancer
(2013-06-01)
The excision repair cross-complementation 1 (ERCC1) enzyme plays an essential role in the nucleotide excision repair pathway and is associated with resistance to platinum-based chemotherapy in different types of cancer. ...
Partial-breast irradiation versus whole-breast radiotherapy for early breast cancer: A systematic review and update meta-analysis
(2020-07-01)
Purpose: The purpose of this study was to compare the treatment outcomes of partial-breast irradiation (PBI) versus whole-breast radiotherapy (WBRT) in early breast cancer. Methods and Materials: Eligible randomized clinical ...
An unusual case of malignant cystosarcoma phyllodes of the breast
(1986-05-01)
A unusually large tumor of the left breast diagnosed as a cystosarcoma phyllodes with multiple malignant sarcomatous changes of the stroma, consisting of liposarcoma, myxoid fibrosarcoma, anaplastic, and giant cell sarcoma ...
An unusual case of malignant cystosarcoma phyllodes of the breast
(1986-05-01)
A unusually large tumor of the left breast diagnosed as a cystosarcoma phyllodes with multiple malignant sarcomatous changes of the stroma, consisting of liposarcoma, myxoid fibrosarcoma, anaplastic, and giant cell sarcoma ...
The evolution of mastectomies in the oncoplastic breast surgery era
(Gland Surgery, 2013)
Over time, surgical techniques have advanced to the point where oncological safety and aesthetic outcomes are the pillars of contemporary breast surgery. Variations of mastectomy came up and started allowing the oncological ...
Recent treatment advances in HER2-positive metastatic breast cancer: a clinical approach
(2012-05)
The use of targeted therapy directed against HER2 is currently the standard of care in patients with metastatic HER2-positive breast cancer. The combination of trastuzumab with a taxane as first-line treatment in HER2-positive ...
Recent treatment advances in HER2-positive metastatic breast cancer: a clinical approach
(2012-05)
The use of targeted therapy directed against HER2 is currently the standard of care in patients with metastatic HER2-positive breast cancer. The combination of trastuzumab with a taxane as first-line treatment in HER2-positive ...
IDO is highly expressed in breast cancer and breast cancer-derived circulating microvesicles and associated to aggressive types of tumors by in silico analysis
(Karger, 2014-07)
Indoleamine-2,3-dioxygenase (IDO) has been established as a normal mechanism of peripheral tolerance and immunosuppression. Besides, malignant tumors release microvesicles (MV) related with tumor dissemination. The aims ...
Breast Cancer: A Public Health Issue that is also Subject of Social Construction
(2020)
Breast cancer claims thousands of lives all over the world every year. A historical perspective on the social construction of breast cancer policy is presented. This mini review examines breast cancer through a historical ...